QNRX ▲ +5.3% - Quoin Pharmaceuticals, Ltd.
$QNRX - Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
14-OCT-2026 06:30 AM ET
Share this post
More filings for $QNRX
QNRX ▲ +1.2% - Quoin Pharmaceuticals, Ltd.Oct 20, 2026QNRX ▼ -1.1% - Quoin Pharmaceuticals, Ltd.Oct 6, 2026QNRX ▲ +8.2% - Quoin Pharmaceuticals, Ltd.Sep 22, 2026QNRX ▼ -1.0% - Quoin Pharmaceuticals, Ltd.Sep 10, 2026QNRX ▼ -0.8% - Quoin Pharmaceuticals, Ltd.Sep 8, 2026QNRX ▲ +1.4% - Quoin Pharmaceuticals, Ltd.Sep 8, 2026
View full $QNRX filing history →💬 Comments
Loading comments…
Leave a comment